| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |